JPMorgan Chase & Co’s Kronos Bio KRON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-441
| Closed | -$364 | – | 6421 |
|
|
2025
Q1 | $364 | Sell |
441
-7
| -2% | -$6 | ﹤0.01% | 5855 |
|
|
2024
Q4 | $426 | Sell |
448
-4
| -0.9% | -$4 | ﹤0.01% | 5764 |
|
|
2024
Q3 | $452 | Buy |
452
+102
| +29% | +$102 | ﹤0.01% | 5741 |
|
|
2024
Q2 | $434 | Hold |
350
| – | – | ﹤0.01% | 5677 |
|
|
2024
Q1 | $455 | Hold |
350
| – | – | ﹤0.01% | 5719 |
|
|
2023
Q4 | $438 | Sell |
350
-1,171
| -77% | -$1.47K | ﹤0.01% | 5903 |
|
|
2023
Q3 | $1.98K | Sell |
1,521
-66,447
| -98% | -$86.4K | ﹤0.01% | 5589 |
|
|
2023
Q2 | $117K | Sell |
67,968
-2,674,233
| -98% | -$4.6M | ﹤0.01% | 4571 |
|
|
2023
Q1 | $4M | Buy |
2,742,201
+172,609
| +7% | +$252K | ﹤0.01% | 2586 |
|
|
2022
Q4 | $4.16M | Buy |
2,569,592
+16,000
| +0.6% | +$25.9K | ﹤0.01% | 2510 |
|
|
2022
Q3 | $8.56M | Sell |
2,553,592
-61,926
| -2% | -$207K | ﹤0.01% | 1976 |
|
|
2022
Q2 | $9.52M | Buy |
2,615,518
+50,471
| +2% | +$184K | ﹤0.01% | 1926 |
|
|
2022
Q1 | $18.5M | Buy |
2,565,047
+1,123,528
| +78% | +$8.12M | ﹤0.01% | 1595 |
|
|
2021
Q4 | $19.6M | Sell |
1,441,519
-46,170
| -3% | -$627K | ﹤0.01% | 1596 |
|
|
2021
Q3 | $31.2M | Sell |
1,487,689
-71,499
| -5% | -$1.5M | ﹤0.01% | 1297 |
|
|
2021
Q2 | $37.3M | Sell |
1,559,188
-63,850
| -4% | -$1.53M | ﹤0.01% | 1238 |
|
|
2021
Q1 | $47.5M | Buy |
1,623,038
+18,277
| +1% | +$535K | 0.01% | 1093 |
|
|
2020
Q4 | $47.9M | Buy |
+1,604,761
| New | +$47.9M | 0.01% | 992 |
|